KRAS and colorectal carcinoma: Therefore, β-elemene can be used as a novel pro-mast disease inducer to inhibit the migration of KRAS-mutated CRC cells and enhance the sensitivity of KRAS-mutated colorectal cancer cells by combining with cetuximab to induce ferroptosis and inhibit EMT [69].